Cargando…
Identification of B cell epitopes enhanced by protein unfolding and aggregation
Aggregation of therapeutic proteins is a key factor in the generation of unwanted immunogenicity, and can result in reduced serum half-life, neutralization of function and adverse health effects. There is currently little information regarding how aggregates interact with B-cell receptors or cognate...
Autores principales: | Eyes, Timothy J., Austerberry, James I., Dearman, Rebecca J., Johannissen, Linus O., Kimber, Ian, Smith, Noel, Thistlethwaite, Angela, Derrick, Jeremy P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344229/ https://www.ncbi.nlm.nih.gov/pubmed/30550980 http://dx.doi.org/10.1016/j.molimm.2018.11.020 |
Ejemplares similares
-
Immunogenicity of therapeutic proteins: Influence of aggregation
por: Ratanji, Kirsty D., et al.
Publicado: (2014) -
Editor’s Highlight: Subvisible Aggregates of Immunogenic Proteins Promote a Th1-Type Response
por: Ratanji, Kirsty D., et al.
Publicado: (2016) -
Influence of Escherichia coli chaperone DnaK on protein immunogenicity
por: Ratanji, Kirsty D., et al.
Publicado: (2016) -
Assessment of the inherent allergenic potential of proteins in mice.
por: Kimber, Ian, et al.
Publicado: (2003) -
The aggregation of cytochrome C may be linked to its flexibility during refolding
por: Austerberry, James I., et al.
Publicado: (2016)